GlassScriptPhysician profile
Craig Scott Turner
NPI 1598738049
$406.52
in general payments reported to CMS, 2019-2025
8 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.89 · 2021: $16.00 · 2022: $12.67 · 2023: $109 · 2024: $71.49 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $244 · Education: $71.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $244.47 |
| Education | $71.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $129.43 | 2023-2024 | Austedo |
| Acadia Pharmaceuticals INC | $93.62 | 2025 | Nuplazid |
| Janssen Pharmaceuticals, INC | $61.61 | 2019-2023 | Xarelto |
| Neurocrine Biosciences, INC. | $41.97 | 2025 | |
| Novartis Pharmaceuticals Corporation | $32.42 | 2019 | |
| Inogen, INC. | $17.61 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Melinta Therapeutics, LLC | $16.00 | 2021 | |
| Abbvie INC. | $13.86 | 2023 | Dalvance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.